Abstract
Amphibians have been favored organisms by experimental embryologists for more than a century. Their large, resilient embryos are ideal for manipulations, such as tissue transplantation, explantation and recombination, methods that have been used to demonstrate the existence and location of inducing centers in developing embryos and to define important embryological principles. Molecular biological approaches developed primarily in Xenopus, including a highly efficient method for transgenesis, have provided another dimension to our understanding of a multitude of cellular and developmental problems. Although there have been many developmental mutants reported in amphibians, mainly in axolotl and Xenopus laevis, amphibians have not been as widely used for genetic approaches as other vertebrates, like the mouse and zebrafish. This has been in part because of the long generation time of these species and their large genome size, especially in the case of axolotl. The duplicated genome of X. laevis also presents potential limitations. But another factor mitigating use of these systems for genetics in past times has been the lack of complementary techniques for studying mutants in detail at the molecular level. A more recently introduced model, Xenopus tropicalis, offers an array of new opportunities for genetic studies. Its short generation time and smaller, diploid genome, together with accumulating genomic resources, make X. tropicalis a very attractive model organism for addressing complex issues in modern cell and developmental biology. Here we will introduce the main features of the X. tropicalis system and briefly discuss possible methodologies for isolating developmental mutants for genetic studies.
Keywords: developmental mutant, genetic screens, genomics, gynogenesis, mutagenesis
Current Genomics
Title: Generation and Characterization of Developmental Mutations in Xenopus tropicalis
Volume: 4 Issue: 8
Author(s): Takuya Nakayama and Robert M. Grainger
Affiliation:
Keywords: developmental mutant, genetic screens, genomics, gynogenesis, mutagenesis
Abstract: Amphibians have been favored organisms by experimental embryologists for more than a century. Their large, resilient embryos are ideal for manipulations, such as tissue transplantation, explantation and recombination, methods that have been used to demonstrate the existence and location of inducing centers in developing embryos and to define important embryological principles. Molecular biological approaches developed primarily in Xenopus, including a highly efficient method for transgenesis, have provided another dimension to our understanding of a multitude of cellular and developmental problems. Although there have been many developmental mutants reported in amphibians, mainly in axolotl and Xenopus laevis, amphibians have not been as widely used for genetic approaches as other vertebrates, like the mouse and zebrafish. This has been in part because of the long generation time of these species and their large genome size, especially in the case of axolotl. The duplicated genome of X. laevis also presents potential limitations. But another factor mitigating use of these systems for genetics in past times has been the lack of complementary techniques for studying mutants in detail at the molecular level. A more recently introduced model, Xenopus tropicalis, offers an array of new opportunities for genetic studies. Its short generation time and smaller, diploid genome, together with accumulating genomic resources, make X. tropicalis a very attractive model organism for addressing complex issues in modern cell and developmental biology. Here we will introduce the main features of the X. tropicalis system and briefly discuss possible methodologies for isolating developmental mutants for genetic studies.
Export Options
About this article
Cite this article as:
Nakayama Takuya and Grainger M. Robert, Generation and Characterization of Developmental Mutations in Xenopus tropicalis, Current Genomics 2003; 4 (8) . https://dx.doi.org/10.2174/1389202033490123
DOI https://dx.doi.org/10.2174/1389202033490123 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epinephrine and its Role in the Development of Obesity and Hypertension
Current Hypertension Reviews Current Trends in the Surgical Armamentarium for Minimally Invasive Heart Valve Therapies
Recent Patents on Biomedical Engineering (Discontinued) Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Current Pharmaceutical Design Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Conserved Domains, Residues, WebLogo and Active Sites of Caspase- Cascades Related to Apoptotic Signaling Pathway
Current Bioinformatics Role of Endothelin in Diabetic Retinopathy
Current Vascular Pharmacology Trends in the Exploration of Anticancer Targets and Strategies in Enhancing the Efficacy of Drug Targeting
Current Molecular Pharmacology Clinical Studies with Paclitaxel - Eluting Stent Systems
Current Pharmaceutical Design The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence
Current Drug Targets The Protective Effects of Levosimendan on Ischemia/Reperfusion Injury and Apoptosis
Recent Patents on Cardiovascular Drug Discovery The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi
Current Topics in Medicinal Chemistry Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry Functional Foods: Salient Features and Clinical Applications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders A Review on Novel Ligand Targeted Delivery for Cardiovascular Disorder
Current Drug Delivery In Utero Gene Therapy: Prospect and Future
Current Pharmaceutical Design Phytotherapeutics against Alzheimer’s Disease: Mechanism, Molecular Targets and Challenges for Drug Development
CNS & Neurological Disorders - Drug Targets Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Leukocyte Influx in Atherosclerosis
Current Drug Targets Modified Fibrin Hydrogel Matrices: Both, 3D-Scaffolds and Local and Controlled Release Systems to Stimulate Angiogenesis
Current Pharmaceutical Design